Ilsung Pharm Total Liabilities

Latest as of June 2026: ₩14.27 Billion KRW ≈ $9.67 Million USD

Ilsung Pharm total liabilities. Based on the latest financial reports, Ilsung Pharm (003120) has total liabilities worth ₩14.27 Billion KRW (≈ $9.67 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Ilsung Pharm liquidity resilience to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Ilsung Pharm (2013–2025)

Total liabilities of Ilsung Pharm from 2013 to 2025. This chart illustrates how Ilsung Pharm's total liabilities have evolved over time, based on quarterly financial data. Explore 003120 strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.

Ilsung Pharm Competitors by Total Liabilities

The table below lists competitors of Ilsung Pharm ranked by their total liabilities.

Company	Country	Total Liabilities
Lily Textile Co Ltd TW:1443	Taiwan	NT$6.06 Billion
Emeren Group Ltd NYSE:SOL	USA	$125.97 Million
Gyldendal ASA OL:GYL	Norway	Nkr1.25 Billion
Nahar Spinning Mills Limited NSE:NAHARSPING	India	Rs11.81 Billion
Ubiquoss Inc KQ:264450	Korea	₩33.78 Billion
Ruentex Materials Co Ltd TW:8463	Taiwan	NT$6.94 Billion
Tait Marketing & Distribution Co Ltd TWO:5902	Taiwan	NT$431.38 Million
Control Print Limited NSE:CONTROLPR	India	Rs-4.51 Billion

Liability Composition Analysis (2013–2025)

This chart breaks down Ilsung Pharm's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see 003120 asset base.

Liquidity & Leverage Metrics

Ilsung Pharm Total Liabilities Ratios Explained

Ilsung Pharm total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	20.42	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.04	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.04	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Ilsung Pharm's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Ilsung Pharm (2013–2025)

The table below shows the annual total liabilities of Ilsung Pharm from 2013 to 2025.

Year	Total Liabilities	Change
2025-12-31	₩16.67 Billion ≈ $11.29 Million	+41.89%
2024-12-31	₩11.75 Billion ≈ $7.96 Million	-67.77%
2023-12-31	₩36.44 Billion ≈ $24.69 Million	-25.42%
2022-12-31	₩48.85 Billion ≈ $33.11 Million	+91.78%
2021-12-31	₩25.47 Billion ≈ $17.26 Million	+7.26%
2020-12-31	₩23.75 Billion ≈ $16.09 Million	-1.16%
2019-12-31	₩24.03 Billion ≈ $16.28 Million	+4.79%
2018-12-31	₩22.93 Billion ≈ $15.54 Million	-6.93%
2017-12-31	₩24.64 Billion ≈ $16.70 Million	+33.88%
2016-12-31	₩18.40 Billion ≈ $12.47 Million	-62.20%
2015-12-31	₩48.69 Billion ≈ $32.99 Million	-2.02%
2014-12-31	₩49.69 Billion ≈ $33.67 Million	-0.45%
2013-12-31	₩49.92 Billion ≈ $33.83 Million	--

About Ilsung Pharm

KO:003120 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$99.50 Million

₩146.82 Billion KRW

Market Cap Rank

#19019 Global

#907 in Korea

Share Price

₩20500.00

Change (1 day)

-0.97%

52-Week Range

₩18300.00 - ₩28300.00

All Time High

₩31693.76